Semaglutide (Weight Loss)
Semaglutide is a revolutionary GLP-1 receptor agonist that was originally developed for patients with Type 2 diabetes, but when physicians noticed how much weight their patients were losing, they began to study Semaglutide exclusively for weight loss. Clinic trials demonstrate that up to 90% of participants using Semaglutide lost at least 5% of their weight; 50% of participants lost 15%; and 30% of participants lost 20%. There is no other weight loss drug or plan on the market that compares. In June, 2022, the FDA approved Semaglutide for weight loss.
How does Semaglutide work?
Semaglutide acts like GLP-1 (a gut hormone) to:
- Increase insulin production
- Decrease glucagon synthesis
- Delay gastric emptying
- Suppress hunger. It signals your brain that you are full so you can lose weight without feeling like you are depriving yourself of calories.